Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Cash Flow Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Quality Index of 1.96x as of September 2025. Operating cash flow of CN¥58.54 Million exceeds net income of CN¥29.92 Million, indicating high earnings quality where cash backs reported profits. Explore Sichuan Huiyu Pharmaceutical Co Ltd (688553) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Sichuan Huiyu Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd (2019–2024)
Year-by-year earnings quality comparison for Sichuan Huiyu Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥242.96 Million | CN¥315.90 Million | ▲ +60.6% |
| 2023 | 0.48x | CN¥66.93 Million | CN¥139.79 Million | ▼ -38.6% |
| 2022 | 0.78x | CN¥194.06 Million | CN¥248.99 Million | ▼ -22.1% |
| 2021 | 1.00x | CN¥446.36 Million | CN¥445.86 Million | ▼ -11.8% |
| 2020 | 1.13x | CN¥387.95 Million | CN¥341.82 Million | ▼ -38.5% |
| 2019 | 1.84x | CN¥326.22 Million | CN¥176.91 Million | — |